Results 211 to 220 of about 22,090 (255)
Some of the next articles are maybe not open access.
On the optimal values of «target» intraocular pressure
National Journal glaucoma, 2022Current statistics show that glaucoma is the main cause of irreversible blindness worldwide. This fact generates continued interest in the search for new methods of rapid and accurate diagnosis of the disease. Presently, reducing the level of intra-ocular pressure (IOP) is the only proven strategy for slowing the progression of glaucomatous optic ...
M. D. Kats, A. V. Kuroyedov
openaire +1 more source
Achieving low target intraocular pressures in severe glaucoma
European Journal of Ophthalmology, 2020Purpose: This study aimed to assess details of therapy required to achieve an intraocular pressure (IOP) of ⩽12 mmHg in patients with severe glaucoma of different etiologies. Methods: Patients with a follow-up of at least 1 year, who fulfilled inclusion criteria were selected, and data analyzed with respect to baseline IOP, number of medications, and ...
Gazella Bruce Warjri +8 more
openaire +2 more sources
New perspectives on target intraocular pressure
Survey of Ophthalmology, 2014The evidence in support of intraocular pressure (IOP) lowering to reduce risk of glaucoma onset or progression is strong, although the amount and quality of IOP reduction is less well defined. The concept of a target IOP includes a percentage reduction, calculated IOP, or a predetermined IOP figure or range.
Clement, Colin I +2 more
openaire +3 more sources
Targeting glaucoma beyond intraocular pressure
Expert Review of Ophthalmology, 2010Primary open-angle glaucoma, as the most prevalent form of glaucoma, is a complex inherited disorder that affects more than 30 million individuals worldwide. It has become increasingly clear that genetic as well as environmental factors have an impact on the development of this disorder.
Bernd Rautenstrauss, Christian Mardin
openaire +1 more source
TARGET INTRAOCULAR PRESSURE IN GLAUCOMA MANAGEMENT
Ophthalmology Clinics of North America, 2000Not long ago in ophthalmology's history, elevated intraocular pressure (IOP) and glaucoma were synonymous: any elevation of IOP was considered glaucoma, and conversely, glaucoma was considered to be caused exclusively by pressure-related damage to the optic nerve head in eyes with elevated IOP.
T REALINI, R FECHTNER
openaire +1 more source
Survey of Ophthalmology, 2008
Early diagnosis of glaucomatous optic nerve damage offers the potential for early treatment which may prevent vision loss from this neurodegenerative disease. Even in patients who do not begin early treatment, early diagnosis allows for better monitoring of disease at a stage where the stakes are lower relative to later stages of the disease. For these
Kuldev, Singh, Anurag, Shrivastava
openaire +2 more sources
Early diagnosis of glaucomatous optic nerve damage offers the potential for early treatment which may prevent vision loss from this neurodegenerative disease. Even in patients who do not begin early treatment, early diagnosis allows for better monitoring of disease at a stage where the stakes are lower relative to later stages of the disease. For these
Kuldev, Singh, Anurag, Shrivastava
openaire +2 more sources
British Journal of Ophthalmology, 2020
AimsTo investigate if eyes presenting intraocular pressure (IOP) within the limits of current guideline-driven target IOP indeed experience slow rates of glaucomatous visual field (VF) progression.MethodsA total of 8598 24-2 VF tests from 603 eyes from the African Descent and Glaucoma Evaluation Study with manifest glaucoma were included.
Bruna Melchior +8 more
openaire +2 more sources
AimsTo investigate if eyes presenting intraocular pressure (IOP) within the limits of current guideline-driven target IOP indeed experience slow rates of glaucomatous visual field (VF) progression.MethodsA total of 8598 24-2 VF tests from 603 eyes from the African Descent and Glaucoma Evaluation Study with manifest glaucoma were included.
Bruna Melchior +8 more
openaire +2 more sources
Canadian perspectives in glaucoma management: setting target intraocular pressure range
Canadian Journal of Ophthalmology, 2003There is an abundance of evidence from recent randomized clinical trials showing that lowering the IOP is beneficial to the optic nerve and visual field. Setting and achieving a target IOP range is in keeping with evidence-based medicine. The benefits of reaching this target must be weighed against the risks of the treatment itself.
Karim F, Damji, Rama, Behki, Lan, Wang
openaire +2 more sources
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2022
Glaucoma is characterized by progressive damage of the retinal ganglion cells (RGCs), resulting in irreversible vision loss. Cannabinoids (CBs) ameliorate several factors that contribute to the progression of glaucoma, including increased intraocular pressure (IOP), degeneration of RGC and optical nerve (ON) damage.
Rishi K, Somvanshi +5 more
openaire +2 more sources
Glaucoma is characterized by progressive damage of the retinal ganglion cells (RGCs), resulting in irreversible vision loss. Cannabinoids (CBs) ameliorate several factors that contribute to the progression of glaucoma, including increased intraocular pressure (IOP), degeneration of RGC and optical nerve (ON) damage.
Rishi K, Somvanshi +5 more
openaire +2 more sources
Mean Target Intraocular Pressure and Progression Rates in Chronic Angle-Closure Glaucoma
Journal of Ocular Pharmacology and Therapeutics, 2009The aim of this study was to evaluate risk factors for progression in chronic angle-closure glaucoma (CACG) patients.A retrospective cohort of patient records in East Asia were evaluated for risk factors associated with progressive optic-disc and visual-field loss.
Ahmad Tajudin Liza, Sharmini +4 more
openaire +2 more sources